Mechanisms that regulate chromosomal stability through the ubiquitin lipase activity of BRCA1
Mechanisms that regulate chromosomal stability through the ubiquitin lipase activity of BRCA1
批准号:
16591280
负责人:
OHTA Tomohiko
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
我在2001年发现BRCA1与BARD1构成了RING异二聚体型泛素连接酶。在这项研究中,我进一步研究了 BRCA1 的底物,以阐明该活性如何促进 BRCA1 维持染色体稳定性的能力。我通过我们最初的筛选方法识别了几种基材。其中我在2004年研究了核磷蛋白/B23(NPM)。BRCA1-BARD1在体内和体外与NPM相互作用并被多泛素化。多泛素化是非传统的Lys-6连接类型,因此NPM不会因修饰而降解,而是稳定化。当 NPM 实际上在体内泛素化时,BRCA1-BARD1 和 NPM 在有丝分裂过程中共定位于染色体表面。我认为 NPM 泛素化的缺乏可能是 BRCA1 缺陷引起的中心体过度扩增和非整倍性的基础。接下来,我在 2005 年分析了另一种候选底物 RPB8。BRCA1-BARD1 在体内和体外与 RPB8 相互作用,并对 RPB8 进行多聚泛素化。在稳定表达 FLAG 标签的 RPB8 的 HeLa 细胞中,紫外线照射 10 分钟后观察到 RPB8 的泛素化,并且这种泛素化被 siRNA 敲低 BRCA1 所消除。有趣的是,稳定表达泛素抗性 RPB8 突变体的 HeLa 细胞表现出紫外线超敏性。结果表明,BRCA1 通过 RPB8 泛素化进行转录偶联 DNA 修复来调节染色体稳定性。
英文摘要
I have discovered in 2001 that BRCA1 constituted a RING heterodimer type ubiquitin ligase with BARD1. In this study I further investigated the substrates of BRCA1 to elacidate how the activity contributed the BRCA1's ability to maintain the chromosomal stability. I identified several substrates by our original screen methods. Among them I have investigated nucleophosmin/B23 (NPM) in 2004. BRCA1-BARD1 interacted with and polyubiquitinated NPM in vivo and in vitro. The polyubiquitination was non-traditional Lys-6-linked type, and therefore NPM was not degraded by the modification and instead stabilized. BRCA1-BARD1 and NPM were co-localized over the chromosomal surface during mitosis when NPM was actually ubiquitinated in vivo. I propose the lack of NPM ubiquitination could be the basis of centrosome hyper amplification and aneuploidy caused by BRCA1 deficiency. I next analyzed another candidate substrate, RPB8, in 2005. BRCA1-BARD1 interacted with and polyubiquitinated RPB8 in vivo and in vitro. The ubiquitination of RPB8 was observed 10 minutes after UV irradiation in HeLa cells stably expressing FLAG-tagged RPB8, and this ubiquitination was abolished by BRCA1 knockdown by siRNA. Interestingly HeLa cells stably expressing ubiquitin-resistant RPB8 mutant exhibited UV hypersensitivity. The results suggested that BRCA1 regulates chromosomal stability by transcription-coupled DNA repair through ubiquitination of RPB8.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Breast tumor suppressor BRCA1
乳腺肿瘤抑制因子 BRCA1
DOI:
--
发表时间:
2004
期刊:
New Horizon Med. (Japanese) 36(4)
影响因子:
--
作者:
[Ohta T, Hayami R, Wu W, Fukuda M.]
通讯作者:
Fukuda M.
DOI:
10.1038/ncb1172
发表时间:
2004-10-01
期刊:
NATURE CELL BIOLOGY
影响因子:
21.3
作者:
[Hu, J, McCall, CM, Xiong, Y]
通讯作者:
Xiong, Y
Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
CDK2 下调 BRCA1-BARD1 泛素连接酶。
DOI:
--
发表时间:
2005
期刊:
Cancer Res. 65
影响因子:
--
作者:
[Hayami R, Sato K, Wu W, Nishikawa T, Hiroi J, Ohtani-Kaneko R, Fukuda M, Ohta T.]
通讯作者:
Ohta T.
DOI:
10.1074/jbc.c400169200
发表时间:
2004-07-23
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Sato, K, Hayami, R, Ohta, T]
通讯作者:
Ohta, T
A truncated splice bariant of human BARD1 that lacks the RING finger and ankyrin repeat.
人类 BARD1 的截短剪接体,缺少环指和锚蛋白重复序列。
DOI:
--
发表时间:
2005
期刊:
Cancer Lett. in press
影响因子:
--
作者:
[Nishida_M, Nagao T, Kurose H.(15), Bravou V. et al., Xouri G. et al., Sugimoto N. et al., Nishitani H. et al., 西谷 秀男, Sei-ichi Tanuma, Sei-ichi Tanuma, Sei-ichi Tanuma, Sei-ichi Tanuma, Sei-ichi Tanuma, 田沼 靖一, Sei-ichi Tanuma, Sei-ichi Tanuma, Sei-ichi Tanuma, Sei-ichi Tanuma, Sei-ichi Tanuma, Atsushi Yamauchi, Vinciane Regnier, Yoshikazu Mikami, 深川竜郎, 深川竜郎, Matsushita N, Makiko Tsuzuki]
通讯作者:
Makiko Tsuzuki
共 11 条
A study of mechanism underlying carcinogenesis promoted by estrogen receptor in BRCA1 deficient cells
-
批准号:16K15712
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.16万
-
财政年份:2016
-
负责人:OHTA Tomohiko
-
依托单位:
Unravelling the mechanism of ovarian carcinogenesis caused by BRCA1 depletion and estrogen action
-
批准号:26670730
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:OHTA Tomohiko
-
依托单位:
Functional analysis of BRCA1 as the molecular basis of breast cancer therapy
-
批准号:26290042
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.65万
-
财政年份:2014
-
负责人:OHTA Tomohiko
-
依托单位:
Research on the breast cancer chemotherapy targeting synthetic lethality caused by the factors in the DNA damage repair pathways.
-
批准号:23300358
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$14.06万
-
财政年份:2011
-
负责人:OHTA Tomohiko
-
依托单位:
Analyses of DNA damage response to neoadjuvant chemotherapy in basal-like breast cancer
-
批准号:20591557
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:OHTA Tomohiko
-
依托单位:
Study of DNA repair mechanisms that affect chemosensitivity of breast cancer
-
批准号:18591446
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.55万
-
财政年份:2006
-
负责人:OHTA Tomohiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向NMD调控BARD1异常剪接体衰变在MDS中的机制研究
-
批准号:82300163
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王路
-
依托单位:
BARD1胚系突变在乳腺癌DNA损伤应答中的作用及潜在临床意义
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:姚璐
-
依托单位:
BARD1识别损伤的染色质并启动同源重组修复的机制研究
-
批准号:32100456
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄艳
-
依托单位:
缺氧诱导的miR-210靶向BARD1调控细胞周期参与子宫内膜异位症的发展
-
批准号:81671435
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张松英
-
依托单位:
BARD1与HUWE1在BRCA1依赖的乳腺癌发生发展中的作用及其机理研究
-
批准号:81602335
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:王晓珍
-
依托单位:
BARD1过表达促进了乳腺癌他莫昔芬耐药的发生
-
批准号:81402505
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:朱英华
-
依托单位:
功能性遗传变异调控BARD1/BRCA1泛素化通路的机制及与儿童神经母细胞瘤的关联研究
-
批准号:31401067
-
项目类别:青年科学基金项目
-
资助金额:28.0万元
-
批准年份:2014
-
负责人:郭永丽
-
依托单位: